Five home-testing devices to diagnose a silent sleep condition seriously harming the health of an estimated 2.5 million adults have been recommended by NICE in draft guidance. An independent NICE ...

If tumour profiling test results indicate that a person is at low risk of cancer recurrence, they may feel more comfortable making the decision to forego chemotherapy. Fewer people having unnecessary ...

Evidence-based recommendations on tumour profiling tests (EndoPredict, ICH4+C, MammaPrint, Oncotype DX and Prosigna) to guide adjuvant chemotherapy decisions in early breast cancer. This guidance ...

Evidence-based recommendations on remdesivir (Veklury) and tixagevimab plus cilgavimab (Evusheld) for treating COVID-19. The government, the NHS or the UK Health Security Agency may choose to use ...

This guidance is a partial review of NICE's diagnostics guidance on tumour profiling tests for guiding adjuvant chemotherapy decisions in early breast cancer (DG34) which made recommendations for ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

The 4 technology appraisal evaluation committees are standing advisory committees of NICE. This topic was considered at the first and second meetings by members from across the 4 committees. At the ...

This topic was considered by the diagnostics advisory committee, which is a standing advisory committee of NICE. Committee members are asked to declare any interests in the test to be evaluated. If it ...

This topic was considered by the diagnostics advisory committee, which is a standing advisory committee of NICE. Committee members are asked to declare any interests in the test to be evaluated. If it ...

Consultation on the draft scope and provisional stakeholder list for the assessment of ‘Tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer’ ...

The tumour profiling tests EndoPredict, MammaPrint, Oncotype DX Breast Recurrence Score, Prosigna and IHC4+C provide information on the activity of genes in tumour samples from people with early ...